最後更新 2024-11-21 16:26:49 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

-6.8%


截至2024-09-28

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

霍洛吉公司(Hologic, Inc.)在美國、歐洲、亞太地區及國際上開發、製造和供應婦女健康診斷產品、醫療影像系統和外科手術產品,以實現早期檢測和治療。該公司通過四個業務部門經營:診斷、乳房健康、婦科外科和骨骼健康。

該公司提供Aptima分子診斷檢測以檢測感染性微生物;Aptima病毒載量檢測用於HIV、丙型肝炎和乙型肝炎;Aptima SARS-CoV-2和Panther Fusion SARS-CoV-2檢測用於檢測SARS-CoV-2;ThinPrep系統用於細胞學應用;Rapid Fetal Fibronectin Test協助醫生評估早產風險;以及各種用於檢測B族鏈球菌的診斷測試。

該公司還提供乳房成像和分析,如2D和3D數字乳腺攝影系統和閱讀工作站、微創乳房活檢導引系統和設備、乳房活檢部位標記和定位、標本放射學以及超聲和連接解決方案;以及乳房保留手術產品。

此外,該公司提供NovaSure子宮內膜消融系統用於治療異常子宮出血;MyoSure宮腔鏡組織切除系統用於切除子宮內的肌瘤、息肉和其他病變;以及Fluent液體管理系統,用於診斷和手術宮腔鏡檢查期間提供液體擴張。

該公司還提供Horizon DXA雙能量X射線系統;以及Fluoroscan Insight FD迷你C臂,用於進行微創骨科手術。

該公司通過直銷和服務團隊以及獨立經銷商和銷售代表銷售其產品。霍洛吉公司成立於1985年,總部位於馬薩諸塞州的馬爾伯勒。



Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

所屬產業

所屬類股
Healthcare
所屬產業
Medical - Instruments & Supplies

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning